BD 328447 - SafetyGlide Insulin Syringe with Needle 0.5 mL 31G x 6 mm 15/64 Inch Sliding Safety Needle (100/BX)

The BD 328447 SafetyGlide Insulin Syringe with Needle is a sterile, single-use insulin delivery device designed to promote accurate dosing and enhanced sharps safety. This 0.5 mL insulin syringe is pre-attached to a 31 gauge, 6 mm (15/64 inch) regular wall needle and features an integrated sliding SafetyGlide shield that helps reduce the risk of accidental needlestick injuries after injection.

Engineered for subcutaneous insulin administration, the fine 31G needle supports patient comfort while maintaining consistent flow performance. The 6 mm needle length is suitable for a wide range of patients and helps support proper subcutaneous delivery when used according to clinical guidelines.

The SafetyGlide sliding shield is designed to be manually activated after injection, locking into place over the needle to provide post-use protection. Manufactured by BD, a leader in injection technology, the 328447 model supports both patient care accuracy and compliance with sharps safety regulations in healthcare environments.

Key Benefits

The 0.5 mL capacity is ideal for patients requiring lower insulin doses, offering clear and precise measurement for accurate administration. The barrel markings are designed for easy readability, helping reduce dosing errors.

The 31 gauge needle supports a more comfortable injection experience by minimizing penetration force and tissue trauma. The 6 mm length is optimized for subcutaneous injections, supporting consistent insulin delivery across a variety of patient body types.

The integrated SafetyGlide sliding shield enhances occupational safety by helping reduce accidental needlestick injuries after use. Once activated, the shield locks into position to cover the needle.

The sterile, single-use design aligns with infection control standards and eliminates the risks associated with reuse. Each syringe is individually packaged to maintain sterility until the point of care.

Compatibility and Applications

The BD 328447 SafetyGlide Insulin Syringe is designed specifically for subcutaneous insulin administration. The fixed needle configuration ensures consistent alignment and dosing accuracy without the need for separate needle attachment.

Typical applications include:

Hospital inpatient diabetes management
Outpatient diabetes clinics
Long-term care facilities
Physician offices
Home healthcare settings

This syringe is commonly used by healthcare professionals and patients managing insulin therapy. The 0.5 mL capacity is particularly suitable for patients prescribed moderate to lower insulin doses.

The product is designed for insulin use and should be used in accordance with prescribing information and clinical guidelines.

Usage Guidelines

Before use, inspect the sterile packaging to ensure it is intact. Do not use if the packaging is damaged or compromised.

Draw the prescribed insulin dose into the syringe if required, following proper technique for vial access. Remove air bubbles and confirm the correct dose using the clear barrel graduations.

Administer the injection subcutaneously according to established clinical practice. After completing the injection, activate the SafetyGlide sliding shield using one-handed technique as directed by the manufacturer. Ensure the shield locks securely over the needle.

Dispose of the used syringe immediately in an approved sharps container. This product is intended for single use only and must not be reused.

Refer to institutional protocols and manufacturer instructions for detailed guidance on insulin administration and safety activation.

Certifications, Safety Standards, and Regulatory Approvals

BD insulin syringes are manufactured in facilities that comply with ISO 13485 quality management standards for medical devices. The BD 328447 SafetyGlide Insulin Syringe meets applicable FDA regulatory requirements for medical devices marketed in the United States.

The integrated safety feature supports compliance with OSHA Bloodborne Pathogens Standard and Needlestick Safety and Prevention Act requirements. These standards are designed to reduce occupational exposure to sharps injuries in healthcare settings.

Regulatory compliance and validated sterility assurance processes contribute to product reliability and patient safety.

Comparison with Competitor Products

Compared to traditional insulin syringes without safety mechanisms, the BD 328447 offers an integrated sliding safety shield that helps reduce needlestick injury risk. This feature is especially valuable in institutional settings where staff safety is a priority.

While many insulin syringes offer 31 gauge needles for patient comfort, BDs manufacturing precision ensures consistent needle sharpness and smooth plunger performance.

The 6 mm needle length aligns with modern recommendations for subcutaneous insulin delivery and may provide advantages over longer needles that increase the risk of intramuscular injection.

Healthcare facilities seeking to balance patient comfort, dosing accuracy, and occupational safety often select BD SafetyGlide insulin syringes for their comprehensive design and reliability.

Typical User Profile and Application Scenarios

The BD 328447 SafetyGlide Insulin Syringe is commonly used by:

Registered nurses
Certified diabetes educators
Physicians
Long-term care staff
Home healthcare caregivers
Patients self-administering insulin

In hospitals and long-term care facilities, the safety feature helps protect staff from accidental needlesticks. In outpatient and home settings, the fine 31G needle supports a more comfortable daily insulin routine.

The syringe is particularly effective in structured insulin therapy programs where accurate dosing and safety compliance are essential.

Best Practices for Use and Maintenance

Store syringes in a clean, dry location within the temperature range specified by the manufacturer. Keep products in original packaging until ready for use to maintain sterility.

Always verify the correct insulin type and prescribed dose before administration. Use appropriate injection site rotation techniques to reduce the risk of lipodystrophy.

Activate the SafetyGlide shield immediately after injection to reduce exposure risk. Never attempt to recap the needle manually.

Dispose of used syringes in designated sharps containers and follow all institutional policies for sharps handling and disposal.

Regular training on insulin administration technique and safety device activation supports consistent and safe use.

Regulatory and Safety Information

The BD 328447 SafetyGlide Insulin Syringe with Needle is a regulated medical device intended for professional and patient use under medical supervision. It is manufactured in accordance with FDA regulations and recognized quality management standards.

The sliding safety mechanism supports compliance with occupational safety regulations designed to reduce needlestick injuries. The sterile, single-use configuration aligns with infection prevention best practices.

Users should follow manufacturer instructions and healthcare provider guidance to ensure safe and effective insulin administration. Any adverse events or product concerns should be reported according to regulatory and institutional procedures.

How to Order

To purchase the BD 328447 SafetyGlide Insulin Syringe 0.5 mL 31G x 6 mm, search for the product number on the CIA Medical website and select the desired quantity. Add the item to your cart and complete the secure checkout process.

For bulk orders, contract pricing, or assistance with product selection, contact CIA Medical customer service at (312) 275-5850. The team can help healthcare facilities and providers maintain a reliable supply of high-quality insulin delivery devices.